127 related articles for article (PubMed ID: 17109468)
1. CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo.
Smith CM; Rosa GT; May JS; Bennett NJ; Mount AM; Belz GT; Stevenson PG
Eur J Immunol; 2006 Dec; 36(12):3186-97. PubMed ID: 17109468
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: activation of virus-specific CD4 T cells throughout γ-herpesvirus latency.
Freeman ML; Burkum CE; Lanzer KG; Jensen MK; Ahmed M; Yager EJ; Flaño E; Winslow GM; Woodland DL; Blackman MA
J Immunol; 2011 Dec; 187(12):6180-4. PubMed ID: 22079983
[TBL] [Abstract][Full Text] [Related]
3. Defining immune engagement thresholds for in vivo control of virus-driven lymphoproliferation.
Godinho-Silva C; Marques S; Fontinha D; Veiga-Fernandes H; Stevenson PG; Simas JP
PLoS Pathog; 2014 Jun; 10(6):e1004220. PubMed ID: 24967892
[TBL] [Abstract][Full Text] [Related]
4. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
Samreen B; Tao S; Tischer K; Adler H; Drexler I
Front Immunol; 2019; 10():2984. PubMed ID: 31921215
[TBL] [Abstract][Full Text] [Related]
5. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection.
Freeman ML; Lanzer KG; Cookenham T; Peters B; Sidney J; Wu TT; Sun R; Woodland DL; Sette A; Blackman MA
J Virol; 2010 Mar; 84(6):2881-92. PubMed ID: 20053740
[TBL] [Abstract][Full Text] [Related]
6. Membrane association of a model CD4
Yunis J; Redwood AJ; Belz GT; Stevenson PG
Immunol Cell Biol; 2020 Apr; 98(4):332-343. PubMed ID: 31997396
[TBL] [Abstract][Full Text] [Related]
7. A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus.
Marques S; Alenquer M; Stevenson PG; Simas JP
PLoS Pathog; 2008 Oct; 4(10):e1000177. PubMed ID: 18846211
[TBL] [Abstract][Full Text] [Related]
8. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.
Sparks-Thissen RL; Braaten DC; Kreher S; Speck SH; Virgin HW
J Virol; 2004 Jul; 78(13):6827-35. PubMed ID: 15194758
[TBL] [Abstract][Full Text] [Related]
9. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.
Braaten DC; Sparks-Thissen RL; Kreher S; Speck SH; Virgin HW
J Virol; 2005 Feb; 79(4):2573-83. PubMed ID: 15681457
[TBL] [Abstract][Full Text] [Related]
10. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection.
Obar JJ; Crist SG; Gondek DC; Usherwood EJ
J Immunol; 2004 Jan; 172(2):1213-9. PubMed ID: 14707099
[TBL] [Abstract][Full Text] [Related]
11. A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection.
Stevenson PG; Boname JM; de Lima B; Efstathiou S
Microbes Infect; 2002 Sep; 4(11):1177-82. PubMed ID: 12361918
[TBL] [Abstract][Full Text] [Related]
12. ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency.
Fowler P; Marques S; Simas JP; Efstathiou S
J Gen Virol; 2003 Dec; 84(Pt 12):3405-3416. PubMed ID: 14645921
[TBL] [Abstract][Full Text] [Related]
13. Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation.
Haas F; Yamauchi K; Murat M; Bernasconi M; Yamanaka N; Speck RF; Nadal D
J Virol; 2014 Sep; 88(17):10002-12. PubMed ID: 24942583
[TBL] [Abstract][Full Text] [Related]
14. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
[TBL] [Abstract][Full Text] [Related]
15. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.
Usherwood EJ; Roy DJ; Ward K; Surman SL; Dutia BM; Blackman MA; Stewart JP; Woodland DL
J Exp Med; 2000 Oct; 192(7):943-52. PubMed ID: 11015436
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.
Hu Z; Blackman MA; Kaye KM; Usherwood EJ
J Immunol; 2015 Mar; 194(6):2746-56. PubMed ID: 25662997
[TBL] [Abstract][Full Text] [Related]
17. Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes.
Swee LK; Guimaraes CP; Sehrawat S; Spooner E; Barrasa MI; Ploegh HL
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1428-33. PubMed ID: 23297227
[TBL] [Abstract][Full Text] [Related]
18. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
Liu L; Usherwood EJ; Blackman MA; Woodland DL
J Virol; 1999 Dec; 73(12):9849-57. PubMed ID: 10559297
[TBL] [Abstract][Full Text] [Related]
19. Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.
Jennings RN; Grayson JM; Barton ES
J Virol; 2014 Dec; 88(24):14040-9. PubMed ID: 25253356
[TBL] [Abstract][Full Text] [Related]
20. The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens.
Gredmark-Russ S; Cheung EJ; Isaacson MK; Ploegh HL; Grotenbreg GM
J Virol; 2008 Dec; 82(24):12205-12. PubMed ID: 18922872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
